ACCOUNTS - Final Accounts


Caseware UK (AP4) 2018.0.196 2018.0.196 2019-03-312019-03-31truetrueFinancingfalse2018-04-01 07577634 2018-04-01 2019-03-31 07577634 2019-03-31 07577634 2018-03-31 07577634 c:Director3 2018-04-01 2019-03-31 07577634 d:CurrentFinancialInstruments 2019-03-31 07577634 d:CurrentFinancialInstruments 2018-03-31 07577634 d:Non-currentFinancialInstruments 2019-03-31 07577634 d:Non-currentFinancialInstruments 2018-03-31 07577634 d:CurrentFinancialInstruments d:WithinOneYear 2019-03-31 07577634 d:CurrentFinancialInstruments d:WithinOneYear 2018-03-31 07577634 d:Non-currentFinancialInstruments d:AfterOneYear 2019-03-31 07577634 d:Non-currentFinancialInstruments d:AfterOneYear 2018-03-31 07577634 d:ShareCapital 2019-03-31 07577634 d:ShareCapital 2018-03-31 07577634 d:RetainedEarningsAccumulatedLosses 2018-04-01 2019-03-31 07577634 d:RetainedEarningsAccumulatedLosses 2019-03-31 07577634 d:RetainedEarningsAccumulatedLosses 2018-03-31 07577634 c:OrdinaryShareClass1 2018-04-01 2019-03-31 07577634 c:OrdinaryShareClass1 2019-03-31 07577634 c:FRS102 2018-04-01 2019-03-31 07577634 c:Audited 2018-04-01 2019-03-31 07577634 c:FullAccounts 2018-04-01 2019-03-31 07577634 c:PrivateLimitedCompanyLtd 2018-04-01 2019-03-31 07577634 c:PublicLimitedCompanyPLCNotQuotedOnAnyExchange 2018-04-01 2019-03-31 07577634 c:SmallCompaniesRegimeForAccounts 2018-04-01 2019-03-31 07577634 4 2018-04-01 2019-03-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 07577634










GCP HEALTHCARE 1 LIMITED

AUDITED
FINANCIAL STATEMENTS

FOR THE YEAR ENDED
31 MARCH 2019



















img7274.png

 


 
GCP HEALTHCARE 1 LIMITED
REGISTERED NUMBER: 07577634

BALANCE SHEET
AS AT 31 MARCH 2019

2019
2018
                                                                      Note
£
£

  

Current assets
  

Debtors: amounts falling due after more than one year
 6 
16,214,448
15,649,119

Debtors: amounts falling due within one year
 6 
115,105
471,457

Cash at bank and in hand
  
267,272
757,801

  
16,596,825
16,878,377

Creditors: amounts falling due within one year
 7 
(500,645)
(900,702)

Net current assets
  
 
 
16,096,180
 
 
15,977,675

Total assets less current liabilities
  
16,096,180
15,977,675

Creditors: amounts falling due after more than one year
 8 
(17,224,365)
(16,949,058)

  

Net liabilities
  
(1,128,185)
(971,383)


Capital and reserves
  

Called up share capital 
 9 
10
10

Profit and loss account
 10 
(1,128,195)
(971,393)

  
(1,128,185)
(971,383)


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Mr R A J Wright
Director

Date: 26 September 2019

The notes on pages 2 to 6 form part of these financial statements.

Page 1

 
GCP HEALTHCARE 1 LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2019

1.


General information

GCP Healthcare 1 Limited is a private company, limited by shares, incorporated in England and Wales, registered number 07577634. The registered office is  24 Savile Row, London, W1S 2ES.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

These financial statements are presented in sterling which is the functional currency of the Company and rounded to the nearest £.

The following principal accounting policies have been applied:

  
2.2

Compliance with accounting standards

The financial statements have been prepared using FRS102 The Financial Reporting Standard applicable in the UK and the Republic of Ireland, including the disclosure and presentation requirements of Section 1A, applicable to small companies. There were no material departures from that standard.

  
2.3

Going concern

The Company made a loss in the year and is in a net liability position at the year end. The Company is part of a financing structure, the underlying loans structured to ensure that actual cash inflows from the loan debtor exceed the Company's cash outflows to service the loan creditor and overheads over the loan term. The directors are therefore satisfied that the Company can meet its liabilities as they fall due. Accordingly, the directors consider that the accounts should be prepared on a going concern basis.

  
2.4
Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured.
Interest receivable is recognised over the loan period using the effective interest method, which takes into account related fees and transaction costs.

 
2.5

Current taxation

Tax is recognised in the Statement of income and retained earnings, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.6

Exceptional items

Exceptional items are transactions that fall within the ordinary activities of the Company but are presented separately due to their size or incidence.

Page 2

 
GCP HEALTHCARE 1 LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2019

2.Accounting policies (continued)

  
2.7
Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at the amount of cash advanced, net of transaction costs charged and are measured subsequently at amortised cost using the effective interest method, less any impairment.

  
2.8
Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

  
2.9
Creditors

Short term creditors are measured at the transaction price. Loans payable to third parties are measured initially at the amount of cash received less transaction costs, and are measured subsequently at amortised cost using the effective interest method.

  
2.10
Interest payable

Interest payable is recognised using the effective interest method, which takes into account related fees and transaction costs. Interest payable is included within cost of sales as it is directly attributable to the interest receivable included in revenue.

 
2.11

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in the case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of income and retained earnings.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

Page 3

 
GCP HEALTHCARE 1 LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2019

3.


Judgements in applying accounting policies and key sources of estimation uncertainty

Estimates and judgements are continually evaluated and are based on historical experience, independent forecasts and other factors that are believed to be reasonable under the circumstances.
The loan interest receivable and payable calculations and the amortised cost balances for other loans receivable and payable assume that all future loan capital and interest receipts and payments will be in accordance with the current loan agreements for the remaining loan term.


4.


Auditors' remuneration

The Company has taken advantage of the exemption not to disclose amounts paid for non audit services as these are disclosed in the group accounts of the parent company.


5.


Employees

There were no employees in the year under review apart from the directors who did not receive any remuneration. 


6.


Debtors

2019
2018
£
£

Due after more than one year

Other debtors
16,214,448
15,649,119


2019
2018
£
£

Due within one year

Other debtors
115,105
471,457


Other debtors comprise loans receivables accounted for at amortised cost.


7.


Creditors: Amounts falling due within one year

2019
2018
£
£

External loans
493,145
891,602

Accruals and deferred income
7,500
9,100

500,645
900,702


Page 4

 
GCP HEALTHCARE 1 LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2019

8.


Creditors: Amounts falling due after more than one year

2019
2018
£
£

External loans
17,224,365
16,949,058


External loans comprise loan notes accounted for at amortised cost.
The loan notes are secured by a debenture over all assets of the Company, present and future.

The aggregate amount of liabilities repayable wholly or in part more than five years after the balance sheet date is:

2019
2018
£
£


Repayable by instalments
15,513,206
16,608,217

Repayable by a bullet repayment
1,360,000
-

16,873,206
16,608,217


9.


Share capital

2019
2018
£
£
Allotted, called up and fully paid



1,000 Ordinary shares of £0.01 each
10
10


10.


Reserves

Profit and loss account

The profit and loss account represents cumulative profits and losses net of all adjustments.


11.


Related party transactions

The Company is exempt under the terms of Financial Reporting Standard 102 (FRS 102) paragraph 33.1A, from disclosing related party transactions with other group companies, on the grounds that the Company is wholly owned within the Group and the Company is included in consolidated financial statements prepared by the Group.


12.


Parent company

The Company's immediate and ultimate parent undertaking is GCP Intermediary Holdings Limited. The consolidated financial statements of GCP Intermediary Holdings Limited may be obtained from Companies House or from its registered office 24 Saville Row, London, W1S 2ES.

Page 5

 
GCP HEALTHCARE 1 LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2019

13.


Auditors' information

The auditors' report on the financial statements for the year ended 31 March 2019 was unqualified.

The audit report was signed on 30 September 2019 by Mark Nelligan ACA (Senior statutory auditor) on behalf of Wellden Turnbull Limited.


Page 6